Frontiers in Molecular Neuroscience,
Год журнала:
2024,
Номер
17
Опубликована: Июнь 17, 2024
Drug
discovery
is
a
generally
inefficient
and
capital-intensive
process.
For
neurodegenerative
diseases
(NDDs),
the
development
of
novel
therapeutics
particularly
urgent
considering
long
list
late-stage
drug
candidate
failures.
Although
our
knowledge
on
pathogenic
mechanisms
driving
neurodegeneration
growing,
additional
efforts
are
required
to
achieve
better
ultimately
complete
understanding
pathophysiological
underpinnings
NDDs.
Beyond
etiology
NDDs
being
heterogeneous
multifactorial,
this
process
further
complicated
by
fact
that
current
experimental
models
only
partially
recapitulate
major
phenotypes
observed
in
humans.
In
such
scenario,
multi-omic
approaches
have
potential
accelerate
identification
new
or
repurposed
drugs
against
multitude
underlying
One
advantage
for
implementation
these
overarching
tools
able
disentangle
disease
states
model
perturbations
through
comprehensive
characterization
distinct
molecular
layers
(i.e.,
genome,
transcriptome,
proteome)
up
single-cell
resolution.
Because
recent
advances
increasing
their
affordability
scalability,
use
omics
technologies
drive
nascent,
but
rapidly
expanding
neuroscience
field.
Combined
with
increasingly
advanced
vitro
models,
which
benefited
from
introduction
human
iPSCs,
multi-omics
shaping
paradigm
NDDs,
prediction
screening.
review,
we
discuss
examples,
main
advantages
open
challenges
targets
therapies
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Ноя. 10, 2023
Abstract
Comprehensive
quantification
of
neuronal
architectures
underlying
anatomical
brain
connectivity
remains
challenging.
We
introduce
a
method
to
identify
distinct
axonal
projection
patterns
from
source
set
target
regions
and
the
count
neurons
with
each
pattern.
A
region
projecting
n
targets
could
have
2
-1
theoretically
possible
types,
although
only
subset
these
types
typically
exists.
By
injecting
uniquely
labeled
retrograde
tracers
in
k
(
<
),
one
can
experimentally
cells
expressing
different
color
combinations
region.
The
counts
for
-choose-
experiments
provide
constraints
model
that
is
robustly
solvable
using
evolutionary
algorithms.
Here,
we
demonstrate
this
method’s
reliability
4
simulated
triple
injection
experiments.
Furthermore,
illustrate
experimental
application
framework
by
quantifying
projections
male
mouse
primary
motor
cortex
secondary
somatosensory
cortices.
Neural Regeneration Research,
Год журнала:
2024,
Номер
20(9), С. 2697 - 2705
Опубликована: Сен. 24, 2024
Many
fields,
such
as
neuroscience,
are
experiencing
the
vast
proliferation
of
cellular
data,
underscoring
need
for
organizing
and
interpreting
large
datasets.
A
popular
approach
partitions
data
into
manageable
subsets
via
hierarchical
clustering,
but
objective
methods
to
determine
appropriate
classification
granularity
missing.
We
recently
introduced
a
technique
systematically
identify
when
stop
subdividing
clusters
based
on
fundamental
principle
that
cells
must
differ
more
between
than
within
clusters.
Here
we
present
corresponding
protocol
classify
datasets
by
combining
data-driven
unsupervised
clustering
with
statistical
testing.
These
general-purpose
functions
applicable
any
dataset
can
be
organized
two-dimensional
matrices
numerical
values,
including
molecular,
physiological,
anatomical
demonstrate
using
from
Janelia
MouseLight
project
characterize
morphological
aspects
neurons.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 27, 2024
Abstract
The
use
of
single
cell/nucleus
RNA
sequencing
(scRNA-seq)
technologies
that
quantitively
describe
cell
transcriptional
phenotypes
is
revolutionizing
our
understanding
biology,
leading
to
new
insights
in
type
identification,
disease
mechanisms,
and
drug
development.
tremendous
growth
scRNA-seq
data
has
posed
challenges
efficiently
characterizing
data-driven
types
identifying
quantifiable
marker
genes
for
classification.
machine
learning
explainable
artificial
intelligence
emerged
as
an
effective
approach
study
large-scale
data.
NS-Forest
a
random
forest
learning-based
algorithm
aims
provide
scalable
solution
identify
minimum
combinations
necessary
sufficient
capture
identity
with
maximum
classification
accuracy.
Here,
we
the
latest
version,
version
4.0
its
companion
Python
package
(
https://github.com/JCVenterInstitute/NSForest
),
several
enhancements
select
gene
exhibit
highly
selective
expression
patterns
among
closely
related
more
perform
selection
atlases
millions
cells.
By
modularizing
final
decision
tree
step,
v4.0
can
be
used
compare
performance
user-defined
computationally-derived
based
on
classifiers.
To
quantify
how
well
identified
markers
desired
pattern
being
exclusively
expressed
at
high
levels
within
their
target
types,
introduce
On-Target
Fraction
metric
ranges
from
0
1,
1
assigned
are
only
not
cells
any
other
types.
outperforms
previous
versions
ability
higher
values
approaches
significantly
F-beta
scores
when
applied
datasets
three
human
organs
-
brain,
kidney,
lung.
Frontiers in Molecular Neuroscience,
Год журнала:
2024,
Номер
17
Опубликована: Июнь 17, 2024
Drug
discovery
is
a
generally
inefficient
and
capital-intensive
process.
For
neurodegenerative
diseases
(NDDs),
the
development
of
novel
therapeutics
particularly
urgent
considering
long
list
late-stage
drug
candidate
failures.
Although
our
knowledge
on
pathogenic
mechanisms
driving
neurodegeneration
growing,
additional
efforts
are
required
to
achieve
better
ultimately
complete
understanding
pathophysiological
underpinnings
NDDs.
Beyond
etiology
NDDs
being
heterogeneous
multifactorial,
this
process
further
complicated
by
fact
that
current
experimental
models
only
partially
recapitulate
major
phenotypes
observed
in
humans.
In
such
scenario,
multi-omic
approaches
have
potential
accelerate
identification
new
or
repurposed
drugs
against
multitude
underlying
One
advantage
for
implementation
these
overarching
tools
able
disentangle
disease
states
model
perturbations
through
comprehensive
characterization
distinct
molecular
layers
(i.e.,
genome,
transcriptome,
proteome)
up
single-cell
resolution.
Because
recent
advances
increasing
their
affordability
scalability,
use
omics
technologies
drive
nascent,
but
rapidly
expanding
neuroscience
field.
Combined
with
increasingly
advanced
vitro
models,
which
benefited
from
introduction
human
iPSCs,
multi-omics
shaping
paradigm
NDDs,
prediction
screening.
review,
we
discuss
examples,
main
advantages
open
challenges
targets
therapies